BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2530536)

  • 1. [Pharmacokinetic properties of cefixime].
    Barré J
    Presse Med; 1989 Oct; 18(32):1578-82. PubMed ID: 2530536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic profile of cefixime in man.
    Faulkner RD; Yacobi A; Barone JS; Kaplan SA; Silber BM
    Pediatr Infect Dis J; 1987 Oct; 6(10):963-70. PubMed ID: 3696837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefixime in the young and elderly.
    Faulkner RD; Bohaychuk W; Lanc RA; Haynes JD; Desjardins RE; Yacobi A; Silber BM
    J Antimicrob Chemother; 1988 Jun; 21(6):787-94. PubMed ID: 3410802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of hepatic failure upon the pharmacokinetics of cefixime].
    Singlas E; Lebrec D; Gaudin C; Montay G; Roche G; Taburet AM
    Presse Med; 1989 Oct; 18(32):1587-8. PubMed ID: 2530538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalency of oral suspension formulations of cefixime.
    Faulkner RD; Sia LL; Barone JS; Forbes SJ; Silber BM
    Biopharm Drug Dispos; 1989; 10(2):205-11. PubMed ID: 2706319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative bioavailability study of cefixime administered as tablets or aqueous solution.
    Montay G; Masala F; Le Roux Y; Le Liboux A; Uhlrich J; Chassard D; Thebault JJ; Roche G; Frydman A
    Drugs; 1991; 42 Suppl 4():6-9. PubMed ID: 1725153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absolute bioavailability of cefixime in man.
    Faulkner RD; Fernandez P; Lawrence G; Sia LL; Falkowski AJ; Weiss AI; Yacobi A; Silber BM
    J Clin Pharmacol; 1988 Aug; 28(8):700-6. PubMed ID: 3216036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent pharmacokinetics of a new oral cephalosporin, cefixime, in the dog.
    Bialer M; Batra VK; Morrison JA; Silber BM; Look ZM; Yacobi A
    Pharm Res; 1987 Feb; 4(1):33-7. PubMed ID: 3508527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tonsillar diffusion of cefixime in children].
    Bégué P; Garabédian N; Quinet B; Baron S
    Presse Med; 1989 Oct; 18(32):1593-5. PubMed ID: 2530540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tonsil diffusion of cefixime in children].
    Bégué P; Garabedian N; Quinet B; Baron S
    Pathol Biol (Paris); 1989 May; 37(5):433-6. PubMed ID: 2780099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
    Kees F; Naber KG
    Infection; 1990; 18 Suppl 3():S150-4. PubMed ID: 2079377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between renal function and disposition of oral cefixime.
    Dhib M; Moulin B; Leroy A; Hameau B; Godin M; Johannides R; Fillastre JP
    Eur J Clin Pharmacol; 1991; 41(6):579-83. PubMed ID: 1815970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
    Mamzoridi K; Kasteridou N; Peonides A; Niopas I
    Pharmacol Toxicol; 1996 Jun; 78(6):417-20. PubMed ID: 8829204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical pharmacology of cefixime in unweaned calves.
    Ziv G; Lavy E; Glickman A; Winkler M
    J Vet Pharmacol Ther; 1995 Apr; 18(2):94-100. PubMed ID: 7629935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative pharmacokinetics of oral ceftibuten, cefixime, cefaclor, and cefuroxime axetil in healthy volunteers.
    Nix DE; Symonds WT; Hyatt JM; Wilton JH; Teal MA; Reidenberg P; Affrime MB
    Pharmacotherapy; 1997; 17(1):121-5. PubMed ID: 9017772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency.
    Guay DR; Meatherall RC; Harding GK; Brown GR
    Antimicrob Agents Chemother; 1986 Sep; 30(3):485-90. PubMed ID: 3777912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of three cefixime formulations.
    Kees F; Naber KG; Sigl G; Ungethüm W; Grobecker H
    Arzneimittelforschung; 1990 Mar; 40(3):293-7. PubMed ID: 2346538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefixime after once-a-day and twice-a-day dosing to steady state.
    Faulkner RD; Bohaychuk W; Desjardins RE; Look ZM; Haynes JD; Weiss AI; Silber BM
    J Clin Pharmacol; 1987 Oct; 27(10):807-12. PubMed ID: 3429686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of cefixime in healthy volunteers after a single oral administration of 200 mg].
    Montay G; Le Liboux A; Thebault JJ; Roche G; Frydman A; Gaillot J
    Presse Med; 1989 Oct; 18(32):1583-6. PubMed ID: 2530537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.